A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions
Clinical trial NCT02201316 · COMPLETED
Trial details
- NCT number
- NCT02201316
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-03
- Primary completion
- 2014-03-18
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.